SWOG S1900A

Primary Category:

Treatment Protocols

Disease Category:

Lung, Lung - Non-Small Cell, Lung - Non-Small Cell Metastatic

Status:

Open

A Phase II Study of Rucaparib in Patients with Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNG-MAP Sub-Study)

NCT#03845296

See Screening Protocol LUNGMAP

Cohort 1 (patients with squamous cell lung cancer) temporarily closed effective July 16, 2020.

Cohort 2 (patients with non-squamous cell lung cancer) is temporarily closed effective April 6, 2020.